Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
bendroflumethiazide | carbonic anhydrase 1 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Heart failure[MeSHID:D006333] Edema[MeSHID:D004487] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
bendroflumethiazide | carbonic anhydrase 2 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Heart failure[MeSHID:D006333] Edema[MeSHID:D004487] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
bendroflumethiazide | carbonic anhydrase 4 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Heart failure[MeSHID:D006333] Edema[MeSHID:D004487] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
bendroflumethiazide | calcium-activated potassium channel subunit alpha-1 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Heart failure[MeSHID:D006333] Edema[MeSHID:D004487] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inducer |
bendroflumethiazide | solute carrier family 12 member 1 | NA | Successful target | TTD , DGIDB | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Heart failure[MeSHID:D006333] Edema[MeSHID:D004487] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
2.27 | approved | unknown |
bendroflumethiazide | solute carrier family 12 member 3 | small molecule | Successful target | TTD , drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Heart failure[MeSHID:D006333] Edema[MeSHID:D004487] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
12.38 | approved | inhibitor |
click here to return to the previous page |